BlauwetLACooperLTIdiopathic giant cell myocarditis and cardiac sarcoidosisHeart Fail Rev2013186733–74610.1007/s10741-012-9358-3
2.
Brilakis ES, Olson LJ, Berry GJ, et al. Survival outcomes of patients with giant cell myocarditis bridged by ventricular assist devices. ASAIO (J Am Soc Artif Intern Organs 1992). 2000; 46(5): 569-572.
3.
CooperDKSchlesingerRGShragoSHeart transplantation for giant cell myocarditisJ Heart Lung Transplant Off Publ Int Soc Heart Transplant1994133555
4.
CooperLTJrBerryGJShabetaiRIdiopathic giant-cell myocarditis—natural history and treatment. Multicenter Giant Cell Myocarditis Study Group InvestigatorsN Engl J Med1997336261860–186610.1056/NEJM199706263362603
5.
CooperLTJrHareJMTazelaarHDUsefulness of immunosuppression for giant cell myocarditisAm J Cardiol2008102111535–1539261386210.1016/j.amjcard.2008.07.041
6.
CooperLTGiant cell and granulomatous myocarditisHeart Fail Clin200513431–43710.1016/j.hfc.2005.06.004
HanawaHKodamaMInomataTAnti-alpha beta T cell receptor antibody prevents the progression of experimental autoimmune myocarditisClin Exp Immunol1994963470–475153457410.1111/j.1365-2249.1994.tb06053.x
9.
HooKimKdeRouxSIgbokweAIgG anti-cardiomyocyte antibodies in giant cell myocarditisAnn Clin Lab Sci200838183–87
10.
KandolinRLehtonenJKupariMCardiac sarcoidosis and giant cell myocarditis as causes of atrioventricular block in young and middle-aged adultsCirc Arrhythm Electrophysiol201143303–30910.1161/CIRCEP.110.959254
11.
KandolinRLehtonenJSalmenkiviKDiagnosis, treatment, and outcome of giant-cell myocarditis in the era of combined immunosuppressionCirc Heart Fail20136115–2210.1161/CIRCHEARTFAILURE.112.969261
12.
KodamaMMatsumotoYFujiwaraMA novel experimental model of giant cell myocarditis induced in rats by immunization with cardiac myosin fractionClin Immunol Immunopathol1990572250–26210.1016/0090-1229(90)90039-S
13.
LarsenBTMaleszewskiJJEdwardsWDAtrial giant cell myocarditis: a distinctive clinicopathologic entityCirculation2013127139–4710.1161/CIRCULATIONAHA.112.128900
14.
MurrayLKGonzález-CostelloJJonasSNVentricular assist device support as a bridge to heart transplantation in patients with giant cell myocarditisEur J Heart Fail2012143312–31810.1093/eurjhf/hfr174
15.
NeumannDABurekCLBaughmanKLCirculating heart-reactive antibodies in patients with myocarditis or cardiomyopathyJ Am Coll Cardiol1990166839–84610.1016/S0735-1097(10)80331-6
16.
RosensteinEDZuckerMJKramerNGiant cell myocarditis: most fatal of autoimmune diseasesSemin Arthritis Rheum20003011–1610.1053/sarh.2000.8367
17.
ShieldsRCTazelaarHDBerryGJThe role of right ventricular endomyocardial biopsy for idiopathic giant cell myocarditisJ Card Fail20028274–7810.1054/jcaf.2002.32196
18.
ToscanoGTartaroPFedrigoMRituximab in recurrent idiopathic giant cell myocarditis after heart transplantation: a potential therapeutic approachTranspl Int Off J Eur Soc Organ Transplant2014275e38–e4210.1111/tri.12270
